Skip to content

The Impact of a Topical Vasodilating Cream on Female Sexual Experience

The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01078077
Acronym
TVConFSD
Enrollment
200
Registered
2010-03-02
Start date
2010-03-31
Completion date
2012-07-31
Last updated
2012-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Sexual Dysfunction

Keywords

healthy females ages twentyfive through sixty

Brief summary

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Detailed description

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Interventions

None listed

Sponsors

West Penn Allegheny Health System
CollaboratorOTHER
Michael Pelekanos MD
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy females ages 25 to sixty sexually active

Exclusion criteria

* Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Countries

United States

Contacts

Primary Contactmichael j pelekanos, MD
mipels@aol.com4128567500
Backup ContactGuy Stofman, MD
guystof@aol.com4123706313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026